Methotrexate for induction of remission in refractory Crohn's disease
about
Anti-IL-12/23p40 antibodies for induction of remission in Crohn's diseaseMethotrexate for induction of remission in ulcerative colitisMethotrexate for induction of remission in refractory Crohn's diseaseHelminth therapy (worms) for induction of remission in inflammatory bowel diseaseProfile of ustekinumab and its potential in patients with moderate-to-severe Crohn's disease.Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectivesUse of methotrexate in inflammatory bowel disease in 2014: A User's Guide.Effectiveness and risk associated with infliximab alone and in combination with immunosuppressors for Crohn's disease: a systematic review and meta-analysisEffectiveness of anti-TNFα for Crohn disease: research in a pediatric learning health system.Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.Management of inflammatory bowel disease in poor responders to infliximab.Asia-Pacific consensus statements on Crohn's disease. Part 2: Management.Low dose thiopurine and allopurinol co-therapy results in significant cost savings at a district general hospital.Proteomic analysis of ascending colon biopsies from a paediatric inflammatory bowel disease inception cohort identifies protein biomarkers that differentiate Crohn's disease from UC
P2860
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
P2860
Methotrexate for induction of remission in refractory Crohn's disease
description
2012 nî lūn-bûn
@nan
2012 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Methotrexate for induction of remission in refractory Crohn's disease
@ast
Methotrexate for induction of remission in refractory Crohn's disease
@en
Methotrexate for induction of remission in refractory Crohn's disease
@en-gb
Methotrexate for induction of remission in refractory Crohn's disease
@nl
type
label
Methotrexate for induction of remission in refractory Crohn's disease
@ast
Methotrexate for induction of remission in refractory Crohn's disease
@en
Methotrexate for induction of remission in refractory Crohn's disease
@en-gb
Methotrexate for induction of remission in refractory Crohn's disease
@nl
prefLabel
Methotrexate for induction of remission in refractory Crohn's disease
@ast
Methotrexate for induction of remission in refractory Crohn's disease
@en
Methotrexate for induction of remission in refractory Crohn's disease
@en-gb
Methotrexate for induction of remission in refractory Crohn's disease
@nl
P2093
P2860
P1476
Methotrexate for induction of remission in refractory Crohn's disease
@en
P2093
David J Tsoulis
John K MacDonald
John WD McDonald
P2860
P356
10.1002/14651858.CD003459.PUB3
P577
2012-12-12T00:00:00Z